India cefixime market is expected
to grow at a steady rate during the forecast period. The India cefixime market
is driven by high use of this medication to treat a number of bacterial
infections. It works by killing bacteria or preventing their growth. Additionally,
the drug is also used to treat typhoid fever which is further expected to boost
the demand through FY2026. Improvement in healthcare infrastructure is further
predicted to bolster the market growth in the years to come.
The India cefixime market is
segmented based on route of administration, dose, source, form, distribution
channel, application, end user, company, and region. Based on form, the market
is segmented into
tablet, capsule, suspension, others. Among them, the tablet segment dominated
the market until 2019 and is further projected to maintain its dominance in the
market during then forecast years as well on account of their longer shelf life
than the alternatives. Also, the capsule segment is anticipated to grow at a
high CAGR in the market over the next 5 years because capsules are considered
as fast-acting and often more powerful than tablet owing to fact that it only
takes few minutes for a liquid filled capsule to disintegrate and get absorbed
into the bloodstream, while it can take 20-30 minutes for a tablet pill to be
absorbed in the human body.
players operating in the India cefixime market are Covalent Laboratories Pvt.
Ltd, Reva Pharma Pvt. Ltd., Orchid Pharma Ltd., Unimark Remedies Ltd., Virchow
Healthcare Pvt. Ltd., Alkem Laboratories Limited, Aurobindo Pharma Limited, Taj
Pharmaceuticals Ltd., Lupin Pharmaceuticals Pvt. Ltd., Dr. Reddy’s Laboratories
Ltd. and others. Major companies are developing advanced technologies, receiving
approvals from regulatory bodies, and launching new products in order to stay
competitive in the market. Other Go-to-Market growth strategies include mergers
& acquisitions, joint ventures, and new product developments in order to
sustain themselves amidst fierce competition.
Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the
- To analyze and estimate the market size of India
cefixime market from FY2016 to FY2019.
- To estimate and forecast the market size of India
cefixime market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India cefixime market
based on route of administration, dose, source, form, distribution
channel, application, end user, company, and regional distribution.
- To identify dominant region or segment in the India
- To identify drivers and challenges for India cefixime
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in India
- To identify and analyze the profile of leading
players operating in India cefixime market.
- To identify key sustainable strategies adopted
by market players in India cefixime market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers which
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of India cefixime market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also studied
by TechSci Research.
Key Target Audience:
- Cefixime manufacturers/
- Market research and
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to cefixime
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
In this report, India cefixime market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Cefixime Market, By Route of Administration:
- India Cefixime Market, By Dose:
- 100 mg
- 200 mg
- 500 mg
- India Cefixime Market, By Source:
- Contract Manufacturing Organizations
- India Cefixime Market, By Form:
- India Cefixime Market, By Distribution Channel:
- India Cefixime Market, By Application:
- India Cefixime Market, By End User:
- India Cefixime Market, By Region:
Company Profiles: Detailed analysis of the major
companies present in India cefixime market.
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
India cefixime market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]
analysis and profiling of additional market players (up to five).